Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Jan 7, 2022; 10(1): 260-267
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.260
Table 1 Status of biomarkers before neoadjuvant chemotherapy and after neoadjuvant chemotherapy
Ref.YearTotal patients (n)Frequency of ER alternation, n (%)
Frequency of PR alternation, n (%)
Frequency of Her-2 alternation, n (%)
Frequency of Ki-67 alternation, n (%)
P × P
P × N
N × P
N × N
P × P
P × N
N × P
N × N
P × P
P × N
N × P
N × N
P × P
P × N
N × P
N × N
Li et al[12]2019565229 (40.5)48 (8.5)53 (9.4)235 (41.6)191 (33.8)76 (13.5)53 (9.4)245 (43.4)439 (39.7)117 (10.6)13 (1.2)536 (48.5)NANANANA
Peng et al[16]201911256 (50.0)18 (16.1)7 (6.2)31 (27.7)32 (28.6)22 (19.6)10 (9.0)48 (42.9)30 (27.8)17 (15.2)6 (5.3)59 (52.7)43 (38.4)42 (37.5)3 (2.7)24 (21.4)
Ahn et al[2]2018442305 (69.0)10 (2.3)8 (1.8)119 (26.9)201 (45.5)65 (14.7)15 (3.4)161 (36.4)109 (24.7)4 (0.9)11 (2.5)318 (71.9)113 (25.6)151 (34.2)12 (2.7)166 (37.6)
Yang et al[17]2018231173 (74.9)NANA3 (1.3)158 (68.4)NANA18 (7.8)26 (11.3)NANA150 (64.9)128 (55.4)NANA48 (20.8)
De La Cruz et al[18]20185419 (35.2)2 (3.7)1 (1.9)9 (16.7)NANANANA5 (9.6)1 (1.9)24 (44.4)NANANANANA
Yoshida et al[19]2017588NANANANANANANANA66 (11.2)33 (5.6)11 (1.9)478 (81.3)NANANANA
Xian et al[20]201777NANA2 (3.0)NANANA2 (3.0)NANANA1 (1.0)NANANANANA
Niikura et al[21]201616580/16515/1627110474 (63.2)499 (3.0)519 (3.1)5088 (30.7)6735 (40.8)1545 (9.4)766 (4.6)7469 (45.9)2210 (13.6)601 (3.7)340 (2.1)9607 (59.0)NANANANA
Gahlaut et al[22]2016133NA7 (5.3)9 (6.8)NANA13 (9.8)5 (3.8)NANA5 (3.8)2 (1.5)NANANANANA
Lim et al[23]2016290189 (65.2)23 (7.9)29 (10.0)49 (16.9)NANANANA65 (22.4)17 (5.9)0 (0.0)208 (71.7)NANANANA
Parinyanitikul et al[10]2015398188 (47.2)23 (5.8)39 (9.8)148 (37.2)105 (26.4)57 (14.3)28 (7.0)207 (52.0)43 (10.8)29 (7.3)11 (2.8)308 (77.4)NANANANA
Zhou et al[24]201510766 (61.7)11 (10.3)4 (3.7)31 (29.0)50 (46.7)13 (12.1)13 (12.1)31 (29.0)39 (36.4)3 (2.8)2 (1.9)63 (58.9)NANANANA
Jin et al[25]2015423202 (47.8)55 (13.0)23 (5.4)143 (33.8)NANANANA55 (13.0)27 (6.4)13 (3.1)328 (77.5)NANANANA
Tan et al[26]201426787 (32.6)57 (21.3)27 (10.1)123 (46.1)78 (29.2)33 (12.4)21 (7.9)135 (50.6)NANANANANANANANA
Yang et al[27]2013113NA6 (5.3)8 (7.1)NANA8 (7.1)10 (8.8)NANA1 (0.9)1 (0.9)NANANANANA
Cockburn et al[28]201313367 (50.4)11 (8.3)1 (0.8)54 (40.6)40 (30.1)16 (12.0)8 (6.0)69 (51.9)24 (18.0)9 (6.8)7 (5.3)93 (69.9)NANANANA
Lee et al[29]201312058 (48.3)11 (9.2)4 (3.3)47 (39.2)26 (21.7)19 (15.8)3 (2.5)72 (60.0)18 (16.8)6 (5.6)5 (4.7)78 (72.9)NANANANA
Dede et al[30]20136329 (46.0)2 (3.2)0 (0.0)4 (6.3)17 (27.0)7 (11.1)3 (4.8)6 (9.5)NANANANANANANANA
Kumaki et al[31]20115330 (56.7)3 (5.7)2 (3.8)18 (34.0)15 (28.3)4 (7.5)3 (5.7)31 (58.5)9 (18.4)5 (10.2)0 (0.0)35 (71.4)NANANANA